Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier.

AUTOR(ES)

Fairweather, N F

RESUMO

A Salmonella typhimurium aroA mutant has been used as a live carrier to immunize mice against tetanus. Plasmid pTETtac4, which expresses a 50-kilodalton fragment of tetanus toxin (fragment C) under the control of the tac promoter, was introduced into SL3261 aroA. When used as a live vaccine and administered orally or intravenously, this strain was able to induce protective immunity in mice against a lethal tetanus toxin challenge. When plasmid pTETtac2, which contains the lacI gene, was used, no immunity was obtained, indicating that the expression of fragment C was repressed in vivo. We believe that this is the first example of a successful oral vaccination that uses an attenuated bacterial carrier to deliver a protective antigen derived from tetanus toxin.

Documentos Relacionados

• Protection against Establishment of Retroviral Persistence by Vaccination with a Live Attenuated Virus
• Influence of preimmunization with tetanus toxoid on immune responses to tetanus toxin fragment C-guest antigen fusions in a Salmonella vaccine carrier.
• Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier.
• Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine.
• Vaccination with Attenuated Neisseria meningitidis Strains Protects against Challenge with Live Meningococci